Indivior PLC (INDV) Key Metrics

NASDAQ: INDVValuation, returns, debt and efficiency ratios over 10 years.

INDV valuation today

Trailing 12 months · as of October 17, 2026
Market cap
$3.83B
Enterprise value
$4.52B
P/E (TTM)
11.6
10-yr median 21.9
Forward P/E
9.5
PEG ratio
—
Price / sales
2.9
10-yr median 2.4
Price / book
145.2
10-yr median 13.1
EV / EBITDA
10.3
10-yr median 12.1
Dividend yield
—
Beta
1.18

INDV key metrics, 2016–2025

Fiscal year ended December 31, 2025 · U.S. dollars

INDV valuation Price multiples at each fiscal year-end price.

P/E ratio−97.4%
21.9
2025 · hover or tap a bar for each year
2016: 82.32017: 67.6 (−17.9%)2018: 3.9 (−94.3%)2019: 2.9 (−24.1%)2021: 13.02024: 826.62025: 21.9 (−97.4%)
20162025
Price / sales+166.4%
3.7
2025 · hover or tap a bar for each year
2016: 2.72017: 3.6 (+31.6%)2018: 1.1 (−70.5%)2019: 0.5 (−52.6%)2020: 1.7 (+231.6%)2021: 3.4 (+102.7%)2022: 3.4 (−0.2%)2023: 2.0 (−41.0%)2024: 1.4 (−29.8%)2025: 3.7 (+166.4%)
20162025
EV / EBITDA−24.1%
15.6
2025 · hover or tap a bar for each year
2016: 16.62017: 8.5 (−48.6%)2018: 1.1 (−87.5%)2021: 7.72024: 20.62025: 15.6 (−24.1%)
20162025
Free cash flow yield−2.3 pts
−2.0%
2025 · hover or tap a bar for each year
2016: 14.1%2017: 6.1% (−8.0 pts)2018: 25.8% (+19.7 pts)2019: 36.7% (+10.8 pts)2020: −18.3% (−55.0 pts)2021: 12.0% (+30.3 pts)2022: −0.3% (−12.3 pts)2023: −16.3% (−16.0 pts)2024: 0.3% (+16.6 pts)2025: −2.0% (−2.3 pts)
20162025

INDV valuation history

Fiscal year-endToday10-year median

INDV returns on capital

ROEROICROA

Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.

INDV debt vs cash

Total debtCash & short-term investments

Debt includes short- and long-term borrowings and, where reported, lease liabilities.

INDV cash returned to shareholders

DividendsBuybacksFree cash flow

INDV price vs earnings per share

Share price at year-endEPS (right axis)

INDV key metrics

2016–2025
Indivior PLC key metrics by fiscal year
2025202420232022202120202019201820172016
Valuation
Market capitalization$4.59B$1.65B$2.17B$3.02B$2.66B$1.07B$392.8M$1.01B$4.12B$2.64B
Enterprise value$4.75B$1.71B$2.04B$2.40B$1.84B$500.6M−$374.2M$331.0M$3.73B$2.48B
P/E ratio21.9826.6——13.0—2.93.967.682.3
Price / sales3.71.42.03.43.41.70.51.13.62.7
Price / book———59.013.113.11.915.4——
Price / free cash flow—330.6——8.3—2.73.916.37.1
Price / operating cash flow—45.9——7.5—2.63.314.06.5
EV / sales3.81.41.92.72.30.8-0.50.33.32.6
EV / EBITDA15.620.6——7.7——1.18.516.6
EV / free cash flow—341.6——5.8——1.314.86.7
Earnings yield4.6%0.1%−6.0%−1.5%7.7%−13.8%34.1%25.9%1.5%1.2%
Free cash flow yield−2.0%0.3%−16.3%−0.3%12.0%−18.3%36.7%25.8%6.1%14.1%
Dividend yield—————————2.6%
Shareholder yield (dividends + buybacks)0.2%10.5%1.5%3.0%3.8%0.0%———2.6%
Share price at fiscal year-end$35.88$12.43$15.27$21.75$17.25$7.33$2.60$6.75$27.50$17.75
Per share
Revenue per share$9.68$8.93$7.71$6.48$5.13$4.41$5.20$6.39$7.67$6.52
Earnings per share$1.64$0.02−$0.91−$0.32$1.33−$1.01$0.89$1.75$0.41$0.22
Operating cash flow per share−$0.21$0.27−$2.12−$0.03$2.29−$1.32$1.00$2.02$1.97$2.74
Free cash flow per share−$0.73$0.04−$2.49−$0.06$2.07−$1.34$0.95$1.74$1.68$2.50
Cash per share$1.52$2.41$2.89$6.46$7.15$5.85$7.02$6.15$5.77$4.66
Book value per share−$0.77−$2.62−$1.35$0.37$1.32$0.56$1.38$0.44−$1.36−$1.98
Tangible book value per share−$0.80−$2.67−$1.47−$0.13$0.78$0.14$0.91$0.44−$1.36−$1.98
Dividends per share—————————$0.46
Capex per share$0.52$0.23$0.37$0.04$0.22$0.03$0.05$0.27$0.29$0.24
Debt per share$2.74$2.82$2.00$1.99$1.85$1.94$1.94$1.60$3.22$3.60
Shares outstanding128.0M133.0M141.8M139.0M154.2M146.6M151.1M150.2M149.7M148.6M
Change in shares outstanding−3.8%−6.2%+2.0%−9.9%+5.2%−3.0%+0.6%+0.4%+0.7%—
Returns & profitability
Return on equity (ROE)———−34.6%143.9%−101.7%97.5%———
Return on assets (ROA)16.6%0.1%−7.3%−2.4%12.2%−9.3%8.4%17.6%4.6%2.7%
Return on tangible assets17.5%0.2%−7.4%−2.6%11.7%−10.1%8.5%17.0%4.2%2.7%
Free cash flow margin−7.6%0.4%−32.3%−1.0%40.3%−30.4%18.3%27.3%21.9%38.4%
Income quality (OCF / net income)−0.1318.00——1.72—1.131.154.8412.70
Financial health
Total debt$351.0M$375.0M$283.0M$277.0M$286.0M$285.0M$293.0M$241.0M$482.0M$535.0M
Cash & short-term investments$195.0M$320.0M$410.0M$897.8M$1.10B$858.0M$1.06B$924.0M$863.0M$692.0M
Net debt$156.0M$55.0M−$127.0M−$620.8M−$816.0M−$573.0M−$767.0M−$683.0M−$381.0M−$157.0M
Debt / equity———5.401.413.481.403.65——
Debt / assets0.290.280.160.160.160.190.180.160.330.44
Net debt / EBITDA0.510.66——−3.43—−3.33−2.20−0.87−1.05
Current ratio0.710.890.981.241.801.981.831.621.430.96
Quick ratio0.550.700.881.121.681.831.731.531.370.92
Interest coverage5.90.8-4.5-2.88.2-6.58.110.28.66.6
Working capital−$262.0M−$100.0M−$24.0M$241.3M$640.0M$588.0M$618.0M$511.0M$371.0M−$40.0M
Invested capital$58.0M−$293.0M−$318.0M−$569.5M−$613.0M−$491.0M−$558.0M−$617.0M−$584.0M−$452.0M
Tangible asset value−$102.0M−$355.0M−$209.0M−$18.7M$121.0M$20.0M$137.0M$66.0M−$203.0M−$295.0M
Net current asset value−$650.0M−$828.0M−$690.0M−$461.5M−$185.0M−$262.0M−$83.0M−$152.0M−$422.0M−$514.0M
Graham number————$6.27—$5.25$4.16——
Graham net-net per share−$6.56−$8.03−$9.08−$4.37−$2.13−$2.59−$1.28−$2.06−$3.78−$4.29
Capital allocation
Dividends paid—————————$69.0M
Share buybacks (net)$11.0M$173.0M$33.0M$90.0M$101.0M$0————
Dividend payout ratio—————————215.3%
Dividends + buybacks / free cash flow————31.7%————18.5%
Capex / revenue5.4%2.6%4.8%0.6%4.3%0.6%0.9%4.3%3.7%3.6%
Capex / operating cash flow—86.1%——9.6%—4.6%13.5%14.6%8.6%
Capex / depreciation3.351.113.530.311.550.150.252.563.312.50
Stock-based compensation / revenue2.1%2.0%1.9%1.8%1.4%1.2%0.4%1.6%1.4%1.0%
R&D / revenue7.8%9.0%10.6%8.2%6.6%6.2%6.8%6.7%8.1%11.2%
SG&A / revenue51.2%52.0%52.1%52.1%30.2%100.3%50.3%———
Efficiency
Days sales outstanding75.078.079.185.597.1119.3112.1101.773.477.2
Days of inventory on hand245.6247.3261.8253.3270.2312.3196.8176.2138.1135.1
Days payables outstanding82.380.675.571.3635.21,721.5711.8117.9108.4108.7
Cash conversion cycle (days)238.2244.7265.4267.5-267.9-1,289.9-402.9160.0103.1103.6
Receivables turnover4.874.684.614.273.763.063.263.594.974.73
Payables turnover4.434.534.835.120.570.210.513.103.373.36
Inventory turnover1.491.481.391.441.351.171.852.072.642.70
Asset turnover0.980.770.620.500.470.410.490.640.870.80
Average receivables$254.5M$254.0M$237.0M$211.0M$210.5M$211.5M$241.0M$267.5M$231.0M$205.0M
Average payables$55.5M$51.0M$36.0M$29.5M$221.0M$457.5M$273.0M$43.5M$36.5M$33.0M
Average inventory$165.5M$156.5M$124.8M$104.8M$94.0M$83.0M$75.5M$65.0M$46.5M$41.0M
Intangibles / total assets0.3%0.5%1.0%3.9%4.5%4.0%4.4%0.0%0.0%0.0%

Computed from INDV's annual financial statements (latest annual report filed February 26, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.

INDV valuation and financial ratios

At the end of fiscal 2025 (December 31, 2025), Indivior traded at 21.9 times earnings, against a 10-year median of 21.9. Based on the latest twelve months, the trailing P/E is 11.6 and the forward P/E is 9.5. It ended the year with $351.0 million of debt and $195.0 million in cash and short-term investments, net debt of $156.0 million. It returned $11.0 million to shareholders: $0 in dividends and $11.0 million in share buybacks. The share count fell 13.9% from 148.6M to 128.0M over 9 years.

See the INDV income statement, the INDV chart for price history, or the INDV stock overview for the latest quote and news.

INDV key metrics FAQ

What is Indivior's P/E ratio?

Indivior's trailing P/E ratio is 11.6 based on the last twelve months of earnings (as of October 17, 2026), and its forward P/E is 9.5. At the end of fiscal 2025 it was 21.9, compared with a 10-year median of 21.9.

What is Indivior's EV/EBITDA?

Indivior's enterprise value was 15.6 times EBITDA at the end of fiscal 2025 (enterprise value $4.7 billion, EBITDA $304.0 million); the current EV/EBITDA is 10.3.

How much debt does Indivior have?

Indivior had total debt of $351.0 million at the end of fiscal 2025 and $156.0 million of net debt (0.51 times EBITDA).

Does Indivior buy back its shares?

Yes. Indivior spent $11.0 million on net share repurchases in fiscal 2025 Shares outstanding changed −3.8% over the year, to 128.0M..

What is Indivior's free cash flow yield?

Indivior generated -$94.0 million of free cash flow in fiscal 2025, a free cash flow yield of −2.0% on its market value at year-end ($4.6 billion).

What is Indivior's current ratio?

Indivior's current ratio was 0.71 at the end of fiscal 2025: current assets were 0.71 times current liabilities.

Drug Manufacturers - Specialty & Generic key metrics